Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study
Article in Haematologica (September 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Haematologica (September 2023)
Article in Open Medicine (January 2021)
Article in International Journal of Hematology (February 2016)